EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multiomics-Based Profiling of the Fecal Microbiome Reveals Potential Disease-Specific Signatures in Pediatric IBD (PIBD)

Anita H DeSantis, Kristina Buss, Keaton M Coker, Brad A Pasternak iD, Jinhua Chi, Jeffrey S Patterson iD, Haiwei Gu, Peter W Jurutka iD, Todd R Sandrin iD

Biomolecules · 2025

DOI: 10.3390/biom15050746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Anita H DeSantis und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematical and Natural Sciences, Arizona State University, 4701 W. Thunderbird Rd, Glendale, AZ 85306, USA. Hauptthemen laut MEDLINE: Feces, Gastrointestinal Microbiome, Inflammatory Bowel Diseases, Colitis, Ulcerative. Die Arbeit nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Phoenix Children's Hospital Foundation Leadership Grant, Phoenix Children’s Hospital Foundation Leadership Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD), which includes Crohn’s Disease (CD) and Ulcerative Colitis (UC), is a chronic gastrointestinal (GI) disorder affecting 1 in 100 people in the United States. Pediatric IBD (PIBD) is estimated to impact 15 per 100,000 children in North America. Factors such as the gut microbiome (GM), genetic predisposition to the disease, and certain environmental factors are thought to be involved in pathogenesis. However, the pathophysiology of IBD is incompletely understood, and diagnostic biomarkers and effective treatments, particularly for PIBD, are limited. Recent work suggests that these factors may interact to influence disease development, and multiomic approaches have emerged as promising tools to elucidate the pathophysiology. We employed metagenomics, metabolomics- and metatranscriptomics-based approaches to examine the microbiome, its genetic potential, and its activity to identify factors associated with PIBD. Metagenomics-based analyses revealed pathways such as octane oxidation and glycolysis that were differentially expressed in UC patients. Additionally, metatranscriptomics-based analyses suggested enrichment of glycan degradation and two component systems in UC samples as well as protein processing in the endoplasmic reticulum, ribosome, and protein export in CD and UC samples. In addition, metabolomics-based approaches revealed patterns of differentially abundant metabolites between healthy and PIBD individuals. Interestingly, overall microbiome community composition (as measured by alpha and beta diversity indices) did not appear to be associated with PIBD. However, we observed a small number of differentially abundant taxa in UC versus healthy controls, including members of the Classes Gammaproteobacteria and Clostridia as well as members of the Family Rikenellaceae. Accordingly, when identifying potential biomarkers for PIBD, our results suggest that multiomics-based approaches afford enhanced potential to detect putative biomarkers for PIBD compared to microbiome community composition sequence data alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FecesGastrointestinal MicrobiomeInflammatory Bowel DiseasesColitis, UlcerativeCrohn DiseaseHumansChildMaleFemaleMetagenomicsMetabolomicsAdolescentBiomarkersTranscriptomeMultiomics

Stichwörter der Autor:innen

Crohn’s DiseaseUlcerative Colitisbiomarkersinflammatory bowel diseasemetabolomicsmetagenomicsmetatranscriptomicsmicrobiomemultiomicspediatric inflammatory bowel disease

Substanzen

Biomarkers

Autor:innen und Institutionen

  • School of Mathematical and Natural Sciences, Arizona State University, 4701 W. Thunderbird Rd, Glendale, AZ 85306, USA.
  • Biosciences Core, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85281, USA.
  • Phoenix Children's Hospital, 1919 E. Thomas Rd, Phoenix, AZ 85016, USA.
  • College of Health Solutions, Health North Building, Arizona State University, 550 N. 3rd St, Suite 501, Phoenix, AZ 85004, USA.
  • College of Medicine, University of Arizona, 475 N. 5th St, Phoenix, AZ 85004, USA.
  • Center for Health through Microbiomes, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85281, USA.

ORCID-Profile: Brad A Pasternak, Jeffrey S Patterson, Peter W Jurutka, Todd R Sandrin

Förderung

  • Phoenix Children's Hospital Foundation Leadership Grant
  • Phoenix Children’s Hospital Foundation Leadership Grant

Zitieren

APA

DeSantis, A. H., Buss, K., Coker, K. M., Pasternak, B. A., Chi, J., Patterson, J. S., Gu, H., Jurutka, P. W., & Sandrin, T. R. (2025). Multiomics-Based Profiling of the Fecal Microbiome Reveals Potential Disease-Specific Signatures in Pediatric IBD (PIBD). Biomolecules. https://doi.org/10.3390/biom15050746

Vancouver

DeSantis AH, Buss K, Coker KM, Pasternak BA, Chi J, Patterson JS, et al. Multiomics-Based Profiling of the Fecal Microbiome Reveals Potential Disease-Specific Signatures in Pediatric IBD (PIBD). Biomolecules. 2025. doi:10.3390/biom15050746

BibTeX
@article{DeSantis2025,
  author = {DeSantis, Anita H and Buss, Kristina and Coker, Keaton M and Pasternak, Brad A and Chi, Jinhua and Patterson, Jeffrey S and Gu, Haiwei and Jurutka, Peter W and Sandrin, Todd R},
  title = {Multiomics-Based Profiling of the Fecal Microbiome Reveals Potential Disease-Specific Signatures in Pediatric IBD (PIBD)},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15050746}
}
Kostenlos starten →